APA (7th ed.) Citation

Y, W., C, L., S, G., B, W., H, W., Z, S., . . . J, H. (2026). CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer. Nature communications. https://doi.org/10.1038/s41467-026-75132-3

Chicago Style (17th ed.) Citation

Y, Wang, et al. "CAF-derived PAI-1 Serves as an EGFR Ligand and Fuels KRAS-mutant Pancreatic Cancer." Nature Communications 2026. https://doi.org/10.1038/s41467-026-75132-3.

MLA (9th ed.) Citation

Y, Wang, et al. "CAF-derived PAI-1 Serves as an EGFR Ligand and Fuels KRAS-mutant Pancreatic Cancer." Nature Communications, 2026, https://doi.org/10.1038/s41467-026-75132-3.